Skip to main content

Table 3 Histological features after eTHE

From: Favourable long-term survival of patients with esophageal cancer treated with extended transhiatal esophagectomy combined with en bloc lymphadenectomy: results from a retrospective observational cohort study

 

eTHE (n = 166)

Tumor localization, n (%)

 Upper third

1 (0.6)

 Middle third

28 (16.9)

 Distal third

137 (82.5)

 AEG Typ I

101 (73.7)

 AEG Typ II

29 (21.2)

Tumor entity, n (%)

 Squamous carcinoma, n (%)

46 (27.7)

 Adenocarcinoma, n (%)

114 (68.7)

 Others

6 (3.6)

(y) pT-Stagea

 ypT0

42 (25.3)

  (y) pT1

46 (27.7)

  (y)pT2

22 (13.3)

  (y)pT3

56 (33.7)

N-Stagea

 pN0

111 (66.9)

 pN1

32 (19.3)

 pN2

16 (9.6)

 pN3

7 (4.2)

TNM 8-Stagea

 I

89 (53.6)

 II

19 (11.4)

 IIIA

15 (9.0)

 IIIB

30 (18.1)

 IVA

7 (4.2)

 IVB

6 (3.6)

RO resection

161 (97.0)

No. of resected lymph nodes

25 (17.0)

Complete response (Becker 1a)a

49 (34.0)

  1. Values are medians (interquartile ranges) unless indicated otherwise
  2. eTHE extended transhiatal esophageal resection with radical bilateral mediastinal en bloc lymphadenectomy
  3. a Values are numbers (percentages)